Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atlanta Seed Company is an Atlanta-based venture capital firm that specializes in early-stage technology investments in the Southeastern United States. Founded in 2016, the firm focuses on pre-seed, seed, and Series A funding for startups across sectors including healthcare technology (HealthTech), medical devices, B2B SaaS, and financial technology (FinTech). The firm aims to bridge the funding gap for regional entrepreneurs and often serves as the first institutional investor in its portfolio companies. Notable health-related investments include ReadiVet, Magnolia Diagnostics, and Copient Health, reflecting a strong interest in digital health and diagnostic innovations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atlanta Seed Company.